Aiming at a Tailored Cure for <i>ERBB2</i>-Positive Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer

Published:2022-04-01 Issue:4 Volume:8 Page:629
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Tarantino Paolo¹²³,Curigliano Giuseppe¹²,Parsons Heather A.³⁴,Lin Nancy U.³⁴,Krop Ian³⁴,Mittendorf Elizabeth A.³⁴⁵,Waks Adrienne³⁴,Winer Eric P.³⁴,Tolaney Sara M.³⁴

Affiliation:

1. Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy

2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy

3. Dana-Farber Cancer Institute, Boston, Massachusetts

4. Harvard Medical School, Boston, Massachusetts

5. Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2788052/jamaoncology_tarantino_2022_rv_210014_1650482080.77048.pdf

Reference63 articles.

1. Breast cancer.;Harbeck;Nat Rev Dis Primers,2019

2. A history of cancer chemotherapy.;DeVita;Cancer Res,2008

3. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.;Stadtmauer;N Engl J Med,2000

4. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).;Cardoso;Ann Oncol,2020

5. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.;Swain;Lancet Oncol,2020

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Palliative surgery versus non-surgery of the solitary metastatic lesion in De novo metastatic breast cancer: A SEER based study;Medicine;2024-06-21

3. Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines;Journal of Nanobiotechnology;2024-06-20

4. Complete response after treatment of breast cancer with isolated liver metastasis: a case report;AME Case Reports;2024-04

5. Comparison of the prognostic effect of pyrotinib plus trastuzumab and chemotherapy different lines therapy in HER2-positive advanced breast cancer;Journal of Chemotherapy;2024-04